Evidence map›Paper›PMID 31239352›Full record

ArticleThe Journal of biological chemistry2019

Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABA

Manasa L Parakala, Yihui Zhang, Amit Modgil, Jayashree Chadchankar, Thuy N Vien, Michael A Ackley, James J Doherty, Paul A Davies, Stephen J Moss

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. New directions in neurosteroid therapeutics in neuropsychiatry.Neuroscience and biobehavioral reviews · 2025
    Review
  8. Neurosteroids: a lifelong impact on brain health.Frontiers in behavioral neuroscience · 2025
    Review
  9. Review
  10. Article
  11. Neurosteroids: mechanistic considerations and clinical prospects.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  12. Neurosteroid influence on affective tone.Neuroscience and biobehavioral reviews · 2023
    Review
  13. GABATrends in pharmacological sciences · 2023
    Review
  14. Review
  15. Neurosteroid enantiomers as potentially novel neurotherapeutics.Neuroscience and biobehavioral reviews · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Manasa L ParakalaDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111.
Yihui ZhangDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111.
Amit ModgilDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111.
Jayashree ChadchankarDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111.
Thuy N VienDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111.
Michael A AckleySage Therapeutics, Cambridge, Massachusetts 02142.
James J DohertySage Therapeutics, Cambridge, Massachusetts 02142.
Paul A DaviesDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111.
Stephen J MossDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111; Department of Neuroscience, Physiology, and Pharmacology, University College, London WC1E 6BT, United Kingdom. Electronic address: Stephen.Moss@Tufts.edu.
Tufts University · USSage Therapeutics (United States) · US

Funding

Modulation of KCC2 activity and the postnatal development of synaptic inhibitionR01NS101888 · NINDS · TUFTS UNIVERSITY BOSTON · PI DEEB, TAREK ZIAD, MOSS, STEPHEN J · 2017 to 2021
$2.3M
Impaired KCC2 function underlies pharmacoresistant seizuresR21NS080064 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2013 to 2014
$452k
NINDS NIH HHS R01 NS101888NINDS NIH HHS R21 NS080064
6 · The paper itself

Abstract

Neuroactive steroids (NASs) are synthesized within the brain and exert profound effects on behavior. These effects are primarily believed to arise from the activities of NASs as positive allosteric modulators (PAMs) of the GABA-type A receptor (GABA

Indexed as

Allosteric RegulationAnimalsCell MembraneEvoked PotentialsGABA-A Receptor AntagonistsHEK293 CellsHippocampusHumansMaleMiceMice, Inbred C57BLMutagenesis, Site-DirectedNeurosteroidsPhosphorylationProtein Kinase CProtein SubunitsGABA-A Receptor AntagonistsNeurosteroidsProtein Kinase CProtein SubunitsReceptors, GABA-AReceptors, ProgesteroneepilepsyGABA receptorgamma-aminobutyric acid (GABA)membrane progesterone receptor (mPR)membrane proteinneuroactive steroidneurosteroidneurotransmissionphosphorylationprogesteroneprotein phosphorylationtonic inhibition

Identifiers

PMID31239352
PMCPMC6690684
OpenAlexW2955950503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.